Showing 1 - 10 of 542
protection. We use new survey data from India, the results of interviews with industry, government and multinational institutions …
Persistent link: https://www.econbiz.de/10012471281
. Using India as an example, it then brings together information gathered from both published sources and personal interviews …
Persistent link: https://www.econbiz.de/10012472451
By thoroughly controlling for the country covariates, through a combination of matched sampling techniques with fixed-effect panel regression models, the analyses arrive at robust results across the various model specifications. First, national pharmaceutical patent protection alone does not...
Persistent link: https://www.econbiz.de/10012462357
We examine the relationship between patent protection for pharmaceuticals and investment in development of new drugs. Patent protection has increased around the world as a consequence of the TRIPS Agreement, which specifies minimum levels of intellectual property protection for members of the...
Persistent link: https://www.econbiz.de/10012463181
A patent only protects an innovator from others producing the same product, but it does not protect him from others producing better products under new patents. Therefore, one may divide up the source of competition facing an innovator into within-patent competition, which results from...
Persistent link: https://www.econbiz.de/10012469403
This paper examines the role of regulation and competition in generic markets. Generics offer large potential savings to payers and consumers of pharmaceuticals. Whether the potential savings are realized depends on the extent of generic entry and uptake and the level of generic prices. In the...
Persistent link: https://www.econbiz.de/10012461428
pharmaceutical trade data from 1996 to 2005, we examine the role of China and India as suppliers of medicines to other middle- and … medicines from high- income countries. We find that imports of antibiotics and unspecified medicaments from India and China … significantly depress the average price of these commodities imported from high-income trading partners, suggesting that India and …
Persistent link: https://www.econbiz.de/10012461408
tuberculosis drug samples that claim to be made in India and were sold in Africa, India, and five mid-income non-African countries … in India or non-African countries. Since this finding is robust for manufacturer-drug fixed effects, one likely …
Persistent link: https://www.econbiz.de/10012458199
This paper examines three sets of explanations for variations in the strength of patent protection across sixty countries and a 150-year period. Wealthier nations are more likely to have patent systems, to allow patentees a longer time to put their patents into practice, and to ratify treaties...
Persistent link: https://www.econbiz.de/10012471298
An extensive theoretical literature has examined the impact of information problems on interactions between government bodies and private firms. One little-explored empirical testing ground is the patent system. This paper examines the administrative practices of patent offices in sixty...
Persistent link: https://www.econbiz.de/10012471299